Back to 
JPMorgan Chase & Co.
JPMorgan Chase & Co.
NAMS
8 quarters
Position history for JPMorgan Chase & Co.'s holdings in NewAmsterdam Pharma Company N.V.
Yes. JPMorgan Chase holds 1,132,955 shares of NAMS (NewAmsterdam Pharma), worth $38.4M, as of its Q2 2026 13F filing. It increased the position by 248,727 shares (+28.1%) from Q1 2026. JPMorgan Chase has held NAMS in every 13F on record since Q3 2024, 8 quarterly filings.
Current Value
$38.4M
Current Shares
1.1M
Total Value Change
+$38M
Total Shares Change
+1.1M
Quarter-by-Quarter History
Other major holders of NAMS: Capital World Investors, FMR LLC, RA Capital Management, L.P.